Neuroendocrine Carcinoma as an Independent Prognostic Factor for Patients With Prostate Cancer: A Population-Based Study
BackgroundNeuroendocrine carcinoma (NEC) is a rare and highly malignant variation of prostate adenocarcinoma. We aimed to investigate the prognostic value of NEC in prostate cancer.MethodsA total of 530440 patients of prostate cancer, including neuroendocrine prostate cancer (NEPC) and adenocarcinom...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2021-12-01
|
| Col·lecció: | Frontiers in Endocrinology |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/articles/10.3389/fendo.2021.778758/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|